University of Texas, M.D. Anderson
Welcome,         Profile    Billing    Logout  
 10 Trials 
16 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Milbourne, Andrea
ART_CIN_II, NCT04098744: Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Recruiting
2
78
US
Artesunate vaginal insert, Artesunic acid, DHA, artemisinin, Placebo vaginal insert
Frantz Viral Therapeutics, LLC, Amarex Clinical Research, M.D. Anderson Cancer Center, Harris Health System (L.B.J. Hospital), The Cleveland Clinic, University of Michigan, Morehouse School of Medicine
CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease
07/25
12/25
NCT00507572: Collection of Outcomes Data for Pregnant Patients with Cancer

Recruiting
N/A
500
US
Medical Chart Review, Chart Review
M.D. Anderson Cancer Center
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
04/25
04/25
Schmeler, Kathleen M
ART_CIN_II, NCT04098744: Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Recruiting
2
78
US
Artesunate vaginal insert, Artesunic acid, DHA, artemisinin, Placebo vaginal insert
Frantz Viral Therapeutics, LLC, Amarex Clinical Research, M.D. Anderson Cancer Center, Harris Health System (L.B.J. Hospital), The Cleveland Clinic, University of Michigan, Morehouse School of Medicine
CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease
07/25
12/25
NCI-2022-03767, NCT05359016: Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique

Recruiting
2
14600
US
HPV testing of women for cervical cancer screening
M.D. Anderson Cancer Center, Population Services International, Eduardo Mondlane University, William Marsh Rice University
Cervical Cancer
02/27
02/27
NCT02714439: Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley

Terminated
1
157
US
Proflavine, Proflavine hemisulfate, High-Resolution Microendoscopy (HRME)
The University of Texas Medical Branch, Galveston, M.D. Anderson Cancer Center, The University of Texas Health Science Center, Houston, William Marsh Rice University
Malignant Neoplasms of Female Genital Organs
02/24
02/24
END CoV-2, NCT04513990: Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19)

Active, not recruiting
N/A
257
US
Biospecimen Collection, Questionnaire Administration
M.D. Anderson Cancer Center, National Cancer Institute (NCI), William Marsh Rice University
COVID-19 Infection
04/23
04/23
NCI-2022-03776, NCT05372484: Rice Technologies for Cervical Cancer Screening and Diagnosis

Recruiting
N/A
678
US, RoW
Multimodal optical imaging
M.D. Anderson Cancer Center, Eduardo Mondlane University, William Marsh Rice University
Cervical Cancer
03/28
03/28
NCI-2018-02553, NCT02140021: Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients with Cervical, Vaginal and Vulvar Dysplasia and Cancer

Active, not recruiting
N/A
409
US
Biospecimen Collection, Laboratory Biomarker Analysis
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Cervical Adenocarcinoma, Cervical Adenocarcinoma in Situ, Cervical Intraepithelial Neoplasia, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Cervical Squamous Intraepithelial Neoplasia, Early Invasive Cervical Adenocarcinoma, Early Invasive Cervical Squamous Cell Carcinoma, High Grade Cervical Squamous Intraepithelial Neoplasia, High Grade Vaginal Intraepithelial Neoplasia, Low Grade Vaginal Intraepithelial Neoplasia, Stage I Cervical Cancer AJCC V8, Stage I Vaginal Cancer AJCC V8, Stage I Vulvar Cancer AJCC V8, Stage IA Cervical Cancer AJCC V8, Stage IA Vaginal Cancer AJCC V8, Stage IA Vulvar Cancer AJCC V8, Stage IA1 Cervical Cancer AJCC V8, Stage IA2 Cervical Cancer AJCC V8, Stage IB Cervical Cancer AJCC V8, Stage IB Vaginal Cancer AJCC V8, Stage IB Vulvar Cancer AJCC V8, Stage IB1 Cervical Cancer AJCC V8, Stage IB2 Cervical Cancer AJCC V8, Stage II Cervical Cancer AJCC V8, Stage II Vaginal Cancer AJCC V8, Stage II Vulvar Cancer AJCC V8, Stage IIA Cervical Cancer AJCC V8, Stage IIA Vaginal Cancer AJCC V8, Stage IIA1 Cervical Cancer AJCC V8, Stage IIA2 Cervical Cancer AJCC V8, Stage IIB Cervical Cancer AJCC V8, Stage IIB Vaginal Cancer AJCC V8, Stage III Cervical Cancer AJCC V8, Stage III Vaginal Cancer AJCC V8, Stage III Vulvar Cancer AJCC V8, Stage IIIA Cervical Cancer AJCC V8, Stage IIIA Vulvar Cancer AJCC V8, Stage IIIB Cervical Cancer AJCC V8, Stage IIIB Vulvar Cancer AJCC V8, Stage IIIC Vulvar Cancer AJCC V8, Stage IV Cervical Cancer AJCC V8, Stage IV Vaginal Cancer AJCC V8, Stage IV Vulvar Cancer AJCC V8, Stage IVA Cervical Cancer AJCC V8, Stage IVA Vaginal Cancer AJCC V8, Stage IVA Vulvar Cancer AJCC V8, Stage IVB Cervical Cancer AJCC V8, Stage IVB Vaginal Cancer AJCC V8, Stage IVB Vulvar Cancer AJCC V8, Vaginal Adenocarcinoma, Vulvar Adenocarcinoma, Vulvar High Grade Squamous Intraepithelial Lesion, Vulvar Intraepithelial Neoplasia, Vulvar Squamous Cell Carcinoma, Vulvar Squamous Intraepithelial Lesion
04/26
04/26
NCT06434337: Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

Recruiting
N/A
600
US
Novel point-of-care diagnostic test for detecting HPV ("Rice HPV test")
M.D. Anderson Cancer Center
Human Papillomavirus
03/26
03/28
NCI-2012-01254, NCT01048853: Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer

Completed
N/A
137
US, RoW
Lymph Node Mapping, lymphatic mapping, Quality-of-Life Assessment, Quality of Life Assessment, Salpingo-Oophorectomy, Sentinel Lymph Node Biopsy, Sentinel Node Biopsy, Sentinel node biopsy alone, SLNB, SNB, Therapeutic Conventional Surgery
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IA2 Cervical Cancer AJCC v6 and v7, Stage IB1 Cervical Cancer AJCC v6 and v7
12/24
12/24
White, Donna
ART_CIN_II, NCT04098744: Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Recruiting
2
78
US
Artesunate vaginal insert, Artesunic acid, DHA, artemisinin, Placebo vaginal insert
Frantz Viral Therapeutics, LLC, Amarex Clinical Research, M.D. Anderson Cancer Center, Harris Health System (L.B.J. Hospital), The Cleveland Clinic, University of Michigan, Morehouse School of Medicine
CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease
07/25
12/25
ART-VIN IIB, NCT06075264: Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

Recruiting
2
27
US
Artesunate ointment, Artesunic acid, Dihydroartemisinin (DHA), Artemisinin, Placebo ointment, Placebo to artesunate ointment
Frantz Viral Therapeutics, LLC, The Cleveland Clinic
Vulvar Diseases, HPV Infection, Vulvar HSIL, Pre-Cancerous Dysplasia, HPV Disease, VIN, Usual Type, VIN 2 of Usual Type, VIN 3 of Usual Type, Vin II, Vin III, VIN Grade 2, VIN Grade 3, High Grade Intraepithelial Neoplasia
12/25
12/26
ENGOT-ov60, NCT04625270 / 2020-004264-26: A Study of Avutometinib (VS-6766) V. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer with and Without a KRAS Mutation

Active, not recruiting
2
225
Europe, Canada, US
avutometinib (VS-6766), avutometinib (VS-6766) and defactinib, avutometinib (VS-6766) and VS-6063
Verastem, Inc., European Network of Gynaecological Oncological Trial Groups (ENGOT), GOG Foundation
Low Grade Ovarian Serous Adenocarcinoma, Ovarian Cancer
11/24
12/26
Gallegos, Jessica
ART_CIN_II, NCT04098744: Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Recruiting
2
78
US
Artesunate vaginal insert, Artesunic acid, DHA, artemisinin, Placebo vaginal insert
Frantz Viral Therapeutics, LLC, Amarex Clinical Research, M.D. Anderson Cancer Center, Harris Health System (L.B.J. Hospital), The Cleveland Clinic, University of Michigan, Morehouse School of Medicine
CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease
07/25
12/25
NCT02606422: tDCS Intervention in Primary Progressive Aphasia

Completed
N/A
61
US
Active HD-tDCS plus Speech-Language Therapy, Sham plus Speech-Language Therapy
Johns Hopkins University, National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD)
Primary Progressive Aphasia, MCI, FTD
07/23
08/23
NCT05978804: Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease

Enrolling by invitation
N/A
50
US
Computerized Cognitive Training via BrainHQ, Active tDCS (tDCS) on DLPFC
Johns Hopkins University, Ybrain Inc.
Mild Cognitive Impairment, Primary Progressive Aphasia, Dementia
08/25
08/25

Download Options